CARDIAC REMODELING MOLECULAR MECHANISMS, TREATMENT AND CLINICAL IMPLICATIONS ; CARDIAC REMODELING MOLECULAR MECHANISMS, TREATMENT AND CLINICAL IMPLICATIONS ; Library of Congress Cataloging-in-Publication Data; CONTENTS ; PREFACE ; Chapter 1 RISK FACTORS FOR CARDIOVASCULAR DISEASE IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; ABSTRACT; 1. INTRODUCTION; Cardiac Disease and ESRD; Uremic Cardiomyopathy ; Left Ventricular Hypertrophy ; Vascular Remodeling and ESRD ; Pathophysiology of the Changes in the Vascular System in ESRD Patients ; Clinical Readings of Arterial Remodeling
Peritoneal Dialysis and Cardiovascular Diseases Traditional Risk Factors in Patients on Peritoneal Dialysis ; 1. Arterial Hypertension ; 2. Atherosclerosis ; 3. Tobacco Smoking ; 4. Obesity ; 5. Dyslipidemia ; Uremia-Related Risk Factors ; 1. Inflammation; 2. Endothelial Dysfunction ; 3. Malnutrition and Protein-Energy Wasting; 4. Oxidative Stress ; 5. Calcification ; 6. Hyperparathyroidism ; 7. Hyperhomocysteinemia ; 8. Insulin Resistance ; 9. Anemia ; Risk Factors Related to Peritoneal Dialysis ; 1. Dialysis Solutions and Advanced Glycation End-Products
2. Residual Renal Function (RRF) 3. Volume Overload and Ultrafiltration Insufficiency ; 4. Genetic and Epigenetic Factors ; 2. AIMS ; 3. METHODS ; Patients ; Echocardiographic Assessment ; Parameters of Peritoneal Dialysis ; Ultrasound Examination of the Carotid Arteries; Statistical Analysis ; 4. RESULTS ; Carotid Artery and Peritoneal Dialysis ; The Relation of Left Ventricular Alterations and Ultrasound Changes of Carotid Arteries in PD Patients ; 5. DISCUSSION ; REFERENCES ; Chapter 2 TROPOMYOSIN: AN EFFECTOR OF CARDIAC REMODELING ; ABSTRACT ; INTRODUCTION
TROPOMYOSIN STRUCTURE AND FUNCTION TPM ISOFORM EXPRESSION IN STRIATED MUSCLE ; TPM ISOFORM KNOCKOUTS AND OVEREXPRESSION IN MICE ; INVOLVEMENT OF TPM IN CARDIAC REMODELING HYPERTROPHY; RESCUE OF THE HCM PHENOTYPE ; INVOLVEMENT OF TPM IN DILATED CARDIOMYOPATHY REMODELING ; TPM PHOSPHORYLATION AND CARDIAC REMODELING ; SUMMARY AND CONCLUSION; REFERENCES ; Chapter 3 IMPACT OF VITAMIN D SYSTEM ON VENTRICULAR REMODELING ; ABSTRACT ; INTRODUCTION ; METABOLISM OF VITAMIN D ; VITAMIN D RECEPTOR ; VITAMIN D CIRCULATING LEVELS AND CARDIOVASCULAR DISEASE: CLINICAL EVIDENCES
VITAMIN D PATHWAY AND CARDIAC HYPERTROPHY CONCLUSION ; REFERENCES ; Chapter 4 EFFECTS OF COFFEE POLYPHENOLS ON MYOCARDIAL REMODELING; ABSTRACT ; 1. INTRODUCTION ; 2. EFFECTS OF CGA ON CARDIOVASCULAR DISEASES IN CLINICAL STUDIES; 3. EFFECTS OF CGA ON CARDIOVASCULAR DISEASES IN ANIMAL STUDIES; 4. CGA ON MYOCARDIAL INFARCTION ; 5. CGA ON MYOCARDITIS ; 6. FUTURE PERSPECTIVES ; CONCLUSION ; ACKNOWLEDGMENTS ; Grants ; REFERENCES ; INDEX
